900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Amenoré, ikke nærmere specificeret	Amenorrhea
Amenorrhoea NOS	Amenorrhea
American Joint Committee on Cancer	American Joint Committee on Cancer allowable value
American trypanosomiasis antibody	Trypanosoma cruzi antibody
tetracain 4 % gel + forbinding	Product containing only tetracaine (medicinal product)
tetracain 4 % gel + okkluderende forbinding	Product containing only tetracaine (medicinal product)
Amethocaine hydrochloride 0.5% conventional release eye drops	Tetracaine hydrochloride 5 mg/mL eye solution
tetracainhydrochlorid 0,5 % øjendråber til engangsbrug	Tetracaine hydrochloride 5 mg/mL eye solution
Amethocaine hydrochloride 1% conventional release eye drops	Tetracaine hydrochloride 10 mg/mL eye solution
tetracainhydrochlorid 1 % øjendråber til engangsbrug	Tetracaine hydrochloride 10 mg/mL eye solution
tetracainhydrochlorid 2 % øjendråber	Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)
ikke-farmaceutisk amphetamin	Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms.
ikke-farmaceutisk amphetaminsulfat	Amfetamine sulfate (substance)
Amidinotransferase	Amidinotransferase
Amikacin 500mg/100mL conventional release solution for infusion	Amikacin only product in parenteral dose form
amikacin 500 mg/100 ml infusionsvæske	Amikacin only product in parenteral dose form
Amiloride hydrochloride	Product containing amiloride (medicinal product)
Amiloride hydrochloride	Product containing amiloride (medicinal product)
Amiloride hydrochloride+bumetanide	Product containing amiloride and bumetanide (medicinal product)
Amino acid injection	Amino acid
Aminosyrer 20 % injektionsvæske, opløsning	Product containing amino acid (product)
Aminosyrer 6 % opløsning	Product containing amino acid (product)
Aminosyrer 6,9 % injektionsvæske, opløsning	Product containing amino acid (product)
Aminosyrer 8 % injektionsvæske, opløsning	Product containing amino acid (product)
Aminosyrer 8,5 % injektionsvæske, opløsning	Product containing amino acid (product)
Aminoacyltransferase	Aminoacyltransferase
Aminobacter niigateaensis	Aminobacter niigataensis (organism)
aminocapronsyre 1,25 g/5 ml oral syrup	Aminocaproic acid 250 mg/mL oral solution
aminocapronsyre 250 mg/ml injektionsvæske, opløsning, ampul	Product containing only aminocaproic acid in parenteral dose form (medicinal product form)
overdosis af aminoglykosider	Aminoglycoside antibacterial overdose (disorder)
Aminophenazone - chemical	Phenazone
aminophyllin 100 mg tablet med modificeret udløsning	Aminophylline only product in oral dose form
Aminophylline 100mg prolonged-release oral tablet	Aminophylline only product in oral dose form
Aminophylline 225mg	Aminophylline hydrate 225 mg prolonged-release oral tablet
aminophyllin 225 mg tablet med modificeret udløsning	Aminophylline hydrate 225 mg prolonged-release oral tablet
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml	Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml	Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
aminophyllin 25 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml	Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
aminophyllin 350 mg tablet med modificeret udløsning	Aminophylline only product in oral dose form
Aminophylline 350mg prolonged-release oral tablet	Aminophylline only product in oral dose form
aminophyllinhydrat tabletter med modificeret udløsning a 100 mg	Aminophylline only product in oral dose form
aminophyllinhydrat tablet med modificeret udløsning a 225 mg	Aminophylline hydrate 225 mg prolonged-release oral tablet
aminophyllinhydrat tablet med modificeret udløsning a 350 mg	Aminophylline only product in oral dose form
Aminotransferase	Aminotransferase
Amitriptyline hydrochloride + perphenazine	Product containing amitriptyline and perphenazine (medicinal product)
Amitriptyline hydrochloride + perphenazine 10mg/2mg tablet	Product containing precisely amitriptyline hydrochloride 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet (clinical drug)
Amitriptyline hydrochloride + perphenazine 25mg/2mg tablet	Amitriptyline hydrochloride 25 mg and perphenazine 2 mg oral tablet
Amitriptyline hydrochloride + perphenazine 25mg/4mg tablet	Product containing precisely amitriptyline hydrochloride 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet (clinical drug)
Amitriptyline hydrochloride + perphenazine 50mg/4mg tablet	Product containing precisely amitriptyline hydrochloride 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet (clinical drug)
amitriptylinhydrochlorid 10 mg opløsning	Amitriptyline-containing product in parenteral dose form
Amitriptyline hydrochloride 10mg/cc	Amitriptyline-containing product in parenteral dose form
Amitriptyline hydrochloride+perphenazine 10mg/4mg tablet	Amitriptyline hydrochloride 10 mg and perphenazine 4 mg oral tablet
amlexanox 2 mg, slimhindeklæbende resoriblet	Amlexanox only product
amlodipinbesilat + benazeprilhydrochlorid	Product containing amlodipine and benazepril (medicinal product)
Amlodipine besylate 10mg	Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release oral tablet (clinical drug)
Amlodipine besylate 10mg tablet	Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release oral tablet (clinical drug)
amlodipinbesilat 2,5 mg tablet	Amlodipine (as amlodipine besilate) 2.5 mg oral tablet
Amlodipine besylate 5mg	Amlodipine (as amlodipine besilate) 5 mg oral tablet
Amlodipine besylate 5mg tablet	Amlodipine (as amlodipine besilate) 5 mg oral tablet
Ammonia-lyase	Ammonia-lyase
Amnestic disorder caused by substance	Amnestic disorder
Amnicator-test for nitrosamin	Measurement of pH in vaginal fluid specimen using nitrazine yellow for detection of rupture of amniotic membrane
Amnicator test NOS	Measurement of pH in vaginal fluid specimen using nitrazine yellow for detection of rupture of amniotic membrane
Amnicator-test negativ	Rupture of amniotic membrane not detected by nitrazine yellow test (finding)
Amnicator-test positiv	Rupture of amniotic membrane detected by nitrazine yellow test
Amniotic fetal cell study NOS	Amniotic fetal cell study
Amniotic fetal cell study NOS	Amniotic fetal cell study
Amniotic fluid - nil abnormal	Finding of condition of amniotic fluid (finding)
amnionvæske - intet abnormt	Finding of condition of amniotic fluid (finding)
Amniotic fluid AFP NOS	Alpha-1-Fetoprotein measurement, amniotic fluid
Amniotic fluid AFP NOS	Alpha-1-Fetoprotein measurement, amniotic fluid
Amniotic fluid appearance NOS	Amniotic fluid appearance
Amniotic fluid appearance NOS	Amniotic fluid appearance, evaluation
Amniotic fluid chemistry NOS	Amniotic fluid chemistry procedure
Amniotic fluid chemistry NOS	Amniotic fluid chemistry procedure
Amniotic fluid exam. NOS	Amniotic fluid examination
Amniotic fluid examination NOS	Amniotic fluid examination
Amniotic fluid microscopy NOS	Amniotic fluid microscopy (procedure)
Amniotic fluid microscopy NOS	Amniotic fluid microscopy (procedure)
Normal amnionvæske	Finding of condition of amniotic fluid (finding)
amnionvæske-lungeemboli, barn født med postnatal komplikation	Amniotic fluid embolism
Amnionvæske-/lungeemboli med prænatal komplikation	Amniotic fluid embolism
Amnionvæske-/lungeemboli med postnatal komplikation	Amniotic fluid embolism
Amnionproblemer, ikke nærmere specificeret	Disorder of amniotic cavity AND/OR membrane
Amniotic problems NOS	Disorder of amniotic cavity AND/OR membrane
Amobarbital sodium + secobarbital sodium	Product containing amobarbital and secobarbital (medicinal product)
amobarbitalnatrium 250 mg injektionsvæske, opløsning, hætteglas	Product containing only amobarbital in parenteral dose form (medicinal product form)
amorolfin 5 % neglelak	Amorolfine (as amorolfine hydrochloride) 50 mg/mL cutaneous solution
amoxicillin + clavulanatkalium 125 mg/31 mg/5 ml sukkerfri suspension	Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug)
amoxicillin + clavulanatkalium tablet med modificeret udløsning a 1 g/62,5 mg	Amoxicillin and clavulanic acid only product in oral dose form
Amoxicillin + clavulanate potassium 1g/62.5mg prolonged-release oral tablet	Amoxicillin and clavulanic acid only product in oral dose form
co-amoxiclav 200 mg/28,5 mg tyggetablet	Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)
co-amoxiclav 200 mg/28,5 mg/5 ml oral suspension	Product containing precisely amoxicillin 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug)
co-amoxiclav 250 mg + 125 mg sukkerfri dispergibel tablet	Amoxicillin and clavulanic acid only product in oral dose form
Amoxicillin + clavulanate potassium 250mg/125mg tablet for conventional release oral suspension	Amoxicillin and clavulanic acid only product in oral dose form
co-amoxiclav 250 mg/62,5 mg tyggetablet	Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet
co-amoxiclav 250 mg/62 mg/5 ml sukkerfri suspension	Product containing precisely amoxicillin 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension (clinical drug)
amoxicillin 400 mg + clavulanatkalium 57 mg tyggetablet	Amoxicillin 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet
amoxicillin + clavulanatkalium 400 mg/57 mg/5 ml sukkerfri suspension	Product containing precisely amoxicillin 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension (clinical drug)
Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL conventional release oral suspension	Amoxicillin 120 mg/mL and clavulanic acid (as clavulanate potassium) 8.58 mg/mL oral suspension
CWD: 600mg/5ml?? amoxicillin 600 mg + clavulanatkalium 600 mg/42,9 mg/5 ml sukkerfri suspension	Amoxicillin 120 mg/mL and clavulanic acid (as clavulanate potassium) 8.58 mg/mL oral suspension

Start Previous Page 10 of 234 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)